Filing Flows

Filing Flows › Companies › United Therapeutics › Earnings quality

United Therapeutics earnings quality score

How much of the reported profit is backed by cash, and how many markers of managed earnings the filings show

Score71 / 100 · grade B · rank 286 of 1027

United Therapeutics (UTHR) scores 71 of 100 for earnings quality, grade B: rank 286 of 1027 companies and 25 of 126 in health. It loses the most points on accruals of -3.0% of assets, higher than 63% of companies (profit backed by cash), Montier C-score 3 of 6 checks failed, discretionary accruals of -4.7% of assets (modified Jones), larger than most. It earns full or near-full marks for Piotroski F-score 8 of 9, adjusted earnings 3% below GAAP, Beneish M-score -2.26: clean (below −2.22).

What earned and lost points

ComponentWhat the filings showPointsOf
Accrualsaccruals of -3.0% of assets, higher than 63% of companies (profit backed by cash)820
Beneish M-scoreBeneish M-score -2.26: clean (below −2.22)1515
Dechow F-scoreDechow F-score 0.36 (normal)1515
Montier C-scoreMontier C-score 3 of 6 checks failed815
Discretionary accrualsdiscretionary accruals of -4.7% of assets (modified Jones), larger than most410
Piotroski F-scorePiotroski F-score 8 of 9910
Non-GAAP gapadjusted earnings 3% below GAAP910
Earnings smoothnessprofit about as variable as cash flow (smoothness 1.00)55
UTHR: share of the available points, by componentUTHR: share of the available points, by componentAccruals38%Discretionary accruals35%Beneish M-score100%Dechow F-score100%Montier C-score50%Piotroski F-score89%Non-GAAP gap90%Earnings smoothness100%

How the score is built

Eight published measures, each scored against the whole universe or on its own scale and weighted: accruals 20, discretionary accruals 10, Beneish M 15, Dechow F 15, Montier C 15, Piotroski F 10, the non-GAAP gap 10, smoothness 5. A measure that cannot be computed (Beneish for a bank, say) drops out and the rest is rescaled, so every company is scored on what applies to it.

Every company ranked → The full quality workbench, live → United Therapeutics: cash flow →

Computed from the companies’ own XBRL filings (latest fiscal year) by published formulas; a statistical screen, not an audit or an accusation. A low score means the reported profit shows more of the markers of managed or low-quality earnings than its peers. Not investment advice.